These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 6599815)
21. The consequences of inescapable shocking: sensitization and motor depression. Golda V; Petr R Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1982; 25(5):403-17. PubMed ID: 6985384 [No Abstract] [Full Text] [Related]
22. [Analysis of the clinical experience with 136 patients with headache treated with lisuride]. Gallo MF; Mallucci C; Martelletti P; Romiti A; Vittorini R; Giacovazzo M Minerva Med; 1984 Jun; 75(25):1515-8. PubMed ID: 6738903 [TBL] [Abstract][Full Text] [Related]
23. Lisuride in extrapyramidal disorders: a possible mechanism of action. Bosio A; Bassi S; Govoni S; Spano PF; Trabucchi M; Covelli V; Frattola L Adv Neurol; 1984; 40():523-6. PubMed ID: 6695630 [No Abstract] [Full Text] [Related]
25. Lisuride in the treatment of myoclonus. Obeso JA; Rothwell JC; Quinn NP; Lang AE; Artieda J; Marsden CD Adv Neurol; 1986; 43():191-6. PubMed ID: 3946110 [No Abstract] [Full Text] [Related]
26. Action of lisuride on reserpine-induced muscular rigidity in rats after local application into the striatum, ventricular space or the spinal subarachnoid space. Flosbach CW; Bräutigam M; Dreesen R; Herken H Arzneimittelforschung; 1982; 32(5):488-91. PubMed ID: 7201824 [TBL] [Abstract][Full Text] [Related]
27. [Determination of growth hormone response to thyreoliberin in the evaluation of lisuride therapy of acromegaly]. Felt V; Nedvídková J Vnitr Lek; 1982 Aug; 28(8):756-61. PubMed ID: 6814061 [No Abstract] [Full Text] [Related]
28. [Lisuride in the treatment of Parkinson syndrome]. Filipová M; Roth B; Kás S; Macek Z; Rozsíval V; Karen P; Votavová M; Krejcová H Cesk Neurol Neurochir; 1987 Mar; 50(2):102-7. PubMed ID: 3581244 [No Abstract] [Full Text] [Related]
29. Differential locomotor responses in male rats from three strains to acute methylphenidate. Amini B; Yang PB; Swann AC; Dafny N Int J Neurosci; 2004 Sep; 114(9):1063-84. PubMed ID: 15370174 [TBL] [Abstract][Full Text] [Related]
30. Pergolide and lisuride in advanced Parkinson's disease. Lieberman AN; Gopinathan G; Neophytides A; Leibowitz M; Goldstein M Adv Neurol; 1984; 40():503-7. PubMed ID: 6695627 [TBL] [Abstract][Full Text] [Related]
32. Genetically based animal model of depression: circadian rhythm of motor activity. Golda V; Petr R Act Nerv Super (Praha); 1990 Jun; 32(2):140-2. PubMed ID: 2399791 [No Abstract] [Full Text] [Related]
33. Elevation of high density lipoproteins in acromegalics after lisuride treatment. Hainer V; Zák A; Sindelková E; Wernischová V; Bĕlikovová H; Skorepa J Horm Metab Res; 1985 Apr; 17(4):220-1. PubMed ID: 4007774 [No Abstract] [Full Text] [Related]
34. Blockade of the behavioral effects of lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamine, quipazine and lisuride by 5-hydroxytryptamine antagonists. Mokler DJ; Commissaris RL; Warner MR; Rech RH J Pharmacol Exp Ther; 1983 Dec; 227(3):557-62. PubMed ID: 6655557 [TBL] [Abstract][Full Text] [Related]
35. Long-term treatment of acromegaly with lisuride: differences of effect on growth hormone and somatomedin. Marek J; Srámková J; Schüllerová M; Stĕpán J; Schreiberová O Endokrinologie; 1981 Dec; 78(2-3):175-85. PubMed ID: 7037372 [No Abstract] [Full Text] [Related]
36. [Use of lisuride in the treatment of anovulatory disorders with prolactinemia]. Uzel R; Závada M; Safarcík K Cesk Gynekol; 1984 Apr; 49(3):186-90. PubMed ID: 6722915 [No Abstract] [Full Text] [Related]
37. Behaviour of genetically hypertensive rats in an animal model of depression and in an animal model of anxiety. Golda V; Petr R Act Nerv Super (Praha); 1986 Dec; 28(4):274-5. PubMed ID: 3825467 [No Abstract] [Full Text] [Related]
38. Intravenous lisuride infusion for Parkinson's disease. Obeso JA; Martinez-Lage JM; Luquin MR; Bolio N Ann Neurol; 1983 Aug; 14(2):252. PubMed ID: 6625541 [No Abstract] [Full Text] [Related]
39. Use of lisuride in advanced Parkinson's disease. Potent dopamine and serotonin agonist. Lieberman AN; Goldstein M; Neophytides A; Leibowitz M; Gopinathan G; Goodgold A; Pact V; Walker R N Y State J Med; 1981 Nov; 81(12):1751-5. PubMed ID: 6949052 [No Abstract] [Full Text] [Related]
40. Bromocriptine and lisuride in Parkinson disease. Lieberman AN; Gopinathan G; Neophytides A; Leibowitz M; Walker R; Hiesiger E Ann Neurol; 1983 Jan; 13(1):44-7. PubMed ID: 6830164 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]